US92764N1028
US92764N1028
Vir Biotechnology, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 66.520.000 | 63.712.000 | 4.4% |
| Cost of Revenue | 26.000 | 845.000 | 96.9% |
| Gross Profit | 66.494.000 | 62.867.000 | 5.8% |
| 546.004.000 | 615.037.000 | 11.2% | |
| Operating Income | -479.510.000 | -552.170.000 | 13.2% |
| Pretax Income | -437.770.000 | -523.105.000 | 16.3% |
| Net Income Common Stockholders | -437.987.000 | -521.960.000 | 16.1% |
| -- | -- | -- | |
| -- | -- | -- |